Briefcases -- Drugs -- ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky

ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. JPML Initial Transfer and Consolidation Order
  2. Initial Case Filing Templates
  3. Court Orders
    1. Case Management Orders (CMOs)
    2. Leadership Committee and Appointments
  4. Evidentiary and Research Documents
    1. FDA Regulatory Materials

Quick Access

  1. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 JPML Initial Transfer Order (February 2, 2018)
  2. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky Electronic Filing Attorney Registration Form
  3. Onglyza MDL 2809 CMO No. 1 Re General Causation Oct 24, 2018.pdf
  4. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order Appointing Plaintiffs' Leadership Structure (September 6, 2018)
  5. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order re: Practice and Procedure (February 9, 2018)
  6. Onglyza (saxagliptin) and Kombiglyze (saxagliptin and metformin) MDL 2809 CMO No. 1 re: General Causation (October 24, 2018)
  7. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order Appointing Plaintiffs' Leadership Structure (September 6, 2018)
  8. FDA Heart Failure Warning re Onglyza (saxagliptin) (April 5, 2016)